133 related articles for article (PubMed ID: 28804820)
21. Underestimation of plasma level of factor V coagulant activity and fibrinogen concentration together with prolonged prothrombin time, activated partial thromboplastin time and thrombin time can result from pre-analytical very low calcium level in citrated sample tube.
d'Audigier C; Delassasseigne C; Robert A; Eschwège V
Int J Lab Hematol; 2016 Feb; 38(1):50-3. PubMed ID: 26406495
[TBL] [Abstract][Full Text] [Related]
22. Clot waveform analysis: Where do we stand in 2017?
Sevenet PO; Depasse F
Int J Lab Hematol; 2017 Dec; 39(6):561-568. PubMed ID: 28876509
[TBL] [Abstract][Full Text] [Related]
23. Sensitivity of commercial prothrombin time reagents to detect coagulation factor deficiencies in equine plasma.
Mischke R; Junker J; Deegen E
Vet J; 2006 Jan; 171(1):114-9. PubMed ID: 16427588
[TBL] [Abstract][Full Text] [Related]
24. Laboratory identification of factor inhibitors: an update.
Kershaw G; Favaloro EJ
Pathology; 2012 Jun; 44(4):293-302. PubMed ID: 22531341
[TBL] [Abstract][Full Text] [Related]
25. Personal practice: An approach to investigation of easy bruising.
Vora A; Makris M
Arch Dis Child; 2001 Jun; 84(6):488-91. PubMed ID: 11369565
[No Abstract] [Full Text] [Related]
26. Laboratory identification of factor inhibitors: the perspective of a large tertiary hemophilia center.
Kershaw G; Jayakodi D; Dunkley S
Semin Thromb Hemost; 2009 Nov; 35(8):760-8. PubMed ID: 20169512
[TBL] [Abstract][Full Text] [Related]
27. Anti-phospholipid syndrome: Current opinion on mechanisms involved, laboratory characterization and diagnostic aspects.
Amiral J; Peyrafitte M; Dunois C; Vissac AM; Seghatchian J
Transfus Apher Sci; 2017 Aug; 56(4):612-625. PubMed ID: 28803708
[TBL] [Abstract][Full Text] [Related]
28. Microkinetic coagulation assays for human and zebrafish plasma.
Iyer N; Jagadeeswaran P
Blood Coagul Fibrinolysis; 2021 Jan; 32(1):50-56. PubMed ID: 33186131
[TBL] [Abstract][Full Text] [Related]
29. Prolonged partial thromboplastin time: To mix or not to mix - is that the question?
Yates SG; Fitts E; De Simone N; Sarode R
Transfus Apher Sci; 2019 Feb; 58(1):39-42. PubMed ID: 30497857
[TBL] [Abstract][Full Text] [Related]
30. Lupus Anticoagulant Testing: Activated Partial Thromboplastin Time (APTT) and Silica Clotting Time (SCT).
Tripodi A; Chantarangkul V
Methods Mol Biol; 2017; 1646():177-183. PubMed ID: 28804829
[TBL] [Abstract][Full Text] [Related]
31. In vitro sensitivity of different activated partial thromboplastin time reagents to mild clotting factor deficiencies.
Toulon P; Eloit Y; Smahi M; Sigaud C; Jambou D; Fischer F; Appert-Flory A
Int J Lab Hematol; 2016 Aug; 38(4):389-96. PubMed ID: 27185477
[TBL] [Abstract][Full Text] [Related]
32. Point-of-care testing of neonatal coagulation.
Tan K; Booth D; Newell SJ; Dear PR; Hughes C; Richards M
Clin Lab Haematol; 2006 Apr; 28(2):117-21. PubMed ID: 16630216
[TBL] [Abstract][Full Text] [Related]
33. A "percent correction" formula for evaluation of mixing studies.
Chang SH; Tillema V; Scherr D
Am J Clin Pathol; 2002 Jan; 117(1):62-73. PubMed ID: 11789732
[TBL] [Abstract][Full Text] [Related]
34. Feasibility of using rotational thromboelastometry to assess coagulation status of combat casualties in a deployed setting.
Doran CM; Woolley T; Midwinter MJ
J Trauma; 2010 Jul; 69 Suppl 1():S40-8. PubMed ID: 20622618
[TBL] [Abstract][Full Text] [Related]
35. Dishomogeneous separation of citrated plasma in primary collection tubes for routine coagulation testing.
Lippi G; Salvagno GL; Bassi A; Montagnana M; Poli G; Guidi GC
Blood Coagul Fibrinolysis; 2008 Jun; 19(4):330-2. PubMed ID: 18469561
[No Abstract] [Full Text] [Related]
36. Clinical implications of clotting screens.
Thorell SE; Nash MJ; Thachil J
Int J Lab Hematol; 2015 Feb; 37(1):8-13. PubMed ID: 24636194
[TBL] [Abstract][Full Text] [Related]
37. [Prothrombin time].
Shimazu C
Nihon Rinsho; 2004 Dec; 62 Suppl 12():586-9. PubMed ID: 15658396
[No Abstract] [Full Text] [Related]
38. The thrombogram in rare inherited coagulation disorders: its relation to clinical bleeding.
Al Dieri R; Peyvandi F; Santagostino E; Giansily M; Mannucci PM; Schved JF; Béguin S; Hemker HC
Thromb Haemost; 2002 Oct; 88(4):576-82. PubMed ID: 12362226
[TBL] [Abstract][Full Text] [Related]
39. Clinical importance of positive test results for lupus anticoagulant and anticardiolipin antibodies.
Proven A; Bartlett RP; Moder KG; Chang-Miller A; Cardel LK; Heit JA; Homburger HA; Petterson TM; Christianson TJ; Nichols WL
Mayo Clin Proc; 2004 Apr; 79(4):467-75. PubMed ID: 15065611
[TBL] [Abstract][Full Text] [Related]
40. Clinical and laboratory diagnosis of rare coagulation disorders (RCDs).
Menegatti M; Palla R
Thromb Res; 2020 Dec; 196():603-608. PubMed ID: 31515069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
